Rhode Island Fines United Over Denials


The wave of managed care consumer protection enforcement hit the Ocean State last month. Rhode Island authorities fined United HealthCare of New England $50,000, alleging that the Warwick, R.I., HMO violated state law in some cases where payments for medications and emergency care were denied.

The state cited United's use of Diversified Pharmaceutical Services, which manages its formulary and, until recently, decided whether off-formulary prescriptions would be covered. Rhode Island law requires state certification — which DPS lacked — for companies performing utilization review.

In addition to paying the fine, United agreed to stop using DPS to rule on medical necessity. It also will suspend reviews of emergency services until it submits a plan for complying with state regulations. Rhode Island allows an HMO to deny emergency care only after one of the plan's physicians consults with the attending physician.

United HealthCare of New England has 232,000 enrollees in Rhode Island and Massachusetts. The company maintained that problems were the result of miscommunication.

Career Opportunities

HAP, a subsidiary of Henry Ford Health System, is a nonprofit health plan providing coverage to individuals, companies and organizations. This executive develops strategies to meet membership and revenue targets through products, pricing, market segmentation and advertising.  Aligns business among Business Development, Commercial Sales, Medicare and Public Sector Programs and Product Development. Seeks to enhance and be responsible for business development and expansion through the development of an effective product portfolio, strong interpersonal relationships and service excellence.

Apply via email to jfedder1@hfhs.org or online at http://p.rfer.us/HENRYFORDlXqAJA

Subscribe to Our Newsletters

Monthly table of contents

Be notified as each issue of Managed Care is available online.

Biweekly newsletter

Recent topics have included:

PTCommunity news

New drug approvals, clinical trials, drug management. Three times per week.